ADAD accounts for less than 1% of all AD cases1 and is comprised of carriers of symptomatic mutations in genes such as amyloid precursor protein (APP), presenilin 1 (PSEN1), or presenilin 2 (PSEN2). The gene discussed is APP; the disease is Alzheimer disease.